Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Consulting agrmnt CC transcript Director departure Inv. presentation
|
Orexigen Therapeutics, Inc. (OREXQ)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/29/2017 |
10-K
| Annual Report for the period ended December 31, 2016 |
02/26/2016 |
10-K
| Annual Report for the period ended December 31, 2015 |
02/27/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
03/13/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
03/14/2013 |
10-K
| Annual Report for the period ended December 31, 2012 |
03/13/2012 |
10-K
| Annual Report for the period ended December 31, 2011 |
03/11/2011 |
10-K
| Annual Report for the period ended December 31, 2010 |
03/11/2010 |
10-K
| Annual Report for the period ended December 31, 2009 |
03/13/2009 |
10-K
| Annual Report for the period ended December 31, 2008 |
03/27/2008 |
10-K
| Annual Report for the period ended December 31, 2007 |
|
|